Active substance
Results for the substance ramucirumab
1 result
About this active substance
Ramucirumab is a monoclonal antibody used in the treatment of certain types of cancer, including gastric cancer and lung cancer.
It works by blocking the VEGFR-2 receptor, which plays a key role in the formation of new blood vessels needed for tumor growth.
It is usually administered in combination with other chemotherapy drugs to enhance treatment effectiveness.
Ramucirumab can slow disease progression and extend survival in patients with advanced cancer.
Common side effects include high blood pressure, diarrhea, fatigue, and an increased risk of bleeding.
Patients should be closely monitored to manage these side effects and assess their response to treatment.
It is essential to discuss the benefits and risks of this treatment with your doctor before starting therapy.